They developed glomerulopathies at the age >50 and had no history of other diseases, despite the presence of anti-nuclear autoantibodies and risk haplotypes in other complement genes (MCP, CFH) [32]. The gene discussed is CD46; the disease is lipoprotein glomerulopathy.